Keywords: Merck Serono, Merck KGaA, Prexton Therapeutics, mGluR programs, Parkinson's disease, Spin-off

Merck Serono sets up Prexton Therapeutics as first spin-off from its Entrepreneur Partnership Program

Article | 31 July 2012

Print This

Merck Serono, a division of Germany’s Merck KGaA (MRK: DE), has created Prexton Therapeutics, the first spin-off company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in